Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05854563Recruiting

Cough Capture as a Portal Into the Lung

Role: collaborator

NCT06278649Not ApplicableNot Yet Recruiting

Relaxation and Guided Imagery as an Intervention for Asthma

Role: collaborator

NCT02977884Not ApplicableCompleted

Complete Health Improvement Program (CHIP) Risk Reduction/Claims Evaluation Project

Role: collaborator

NCT03193125Not ApplicableCompleted

Carnitine and Liver Mitochondria Fatty Acid Processing

Role: collaborator

NCT00714129Not ApplicableCompleted

De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver Disease

Role: collaborator

NCT01200043Not ApplicableCompleted

Metabolic Impact of Fructose Restriction in Obese Children

Role: collaborator

All 6 trials loaded